Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety evaluation of Ginkgo Leaf Dripping Pill
ChiCTR-OPN-17014067Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jun 2016
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ginkgo leaf dropping pill in coronary arteriosclerosis, stable angina and brain infarction, sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoint: Adverse reaction. Started Jun 2016; status: recruiting.
02
Drugs
ginkgo leaf dropping pill
03
Conditions
coronary arteriosclerosisstable anginabrain infarction
Beyond the preview
Go deeper on ChiCTR-OPN-17014067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17014067.